Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

CREW Asks for Investigation into Why Wall Street Is Getting H1N1 Vaccine Ahead of Those Who Most Need It

WASHINGTON - 
      Today, Citizens for Responsibility and Ethics in Washington (CREW) asked 
      Health and Human Service (HHS) Secretary Kathleen Sebelius to 
      investigate why the Center for Disease Control (CDC) approved the 
      distribution of the H1NI vaccine to Wall Street firms at a time when the
Posted : Thu, 05 Nov 2009 17:37:36 GMT
Author : Citizens for Responsibility and Ethics in Washington (CREW)
Category : Press Release
News Alerts by Email ( click here )
Press Release News | Home
WASHINGTON - (Business Wire) Today, Citizens for Responsibility and Ethics in Washington (CREW) asked Health and Human Service (HHS) Secretary Kathleen Sebelius to investigate why the Center for Disease Control (CDC) approved the distribution of the H1NI vaccine to Wall Street firms at a time when the vaccine is unavailable to most Americans.

Recent news reports indicate 13 companies, including Citigroup, Goldman Sachs, JP Morgan Chase and Time Warner, have been cleared to receive the vaccine.

The CDC is distributing the much sought-after vaccine to Wall Street firms despite reports of vast shortages. In fact, just yesterday CDC Director Thomas Frieden informed Congress that only 32.3 million doses are available, far less than the 159 million needed to cover those at the highest risk. Given the scarce supply, the CDC has recommended the vaccine be directed only to those at highest risk: pregnant women, infants and children and those up to 24 years, those who care for infants, health and emergency services personnel, and adults with compromised immune systems or other chronic health problems.

Melanie Sloan, executive director of CREW, said today, “Although CREW has been unable to uncover the demographic makeup of Goldman Sachs, Citigroup, and JP Morgan Chase, it seems safe to assume the vast majority of their employees are not pregnant women, infants and children, young adults up to 24 years old, and healthcare workers.”

State officials are concerned about the shortages. The head of Alabama’s Department of Public Health testified that 62% of the vaccines ordered by the state will not be available until after December 1, 2009 and the director of Minnesota’s St. Paul Ramsey County Department of Public Health said he is expecting only 7,800 doses for more than 20,000 children. Los Angeles County’s three public hospitals ordered 110,000 vaccines, but have received only about 18,000 doses, and UCLA’s two hospitals received 1,000 doses for 10,000 staff and 35,000 patients.

This situation is echoed around the country, leaving most of those seeking the vaccine unable to receive it with no remedy in sight. Frieden admitted, “It is quite likely the current wave of influenza will peak, crest and begin to decline before there are ample supplies of the vaccine.”

Sloan said, “In what world do Wall Street employees deserve to be vaccinated ahead of high-risk children, pregnant women and health care workers? Unfortunately, for the thousands being turned away in clinics across America, the CDC has decided to prioritize the millionaires over the masses. The public has a right to know how and why this has happened and when it will stop.” Sloan continued, “First, the bailout, then the bonuses, now the vaccine. When will Washington start putting the needs of Main Street above those of Wall Street?”

Click here to read CREW’s letter to HHS.

Citizens for Responsibility and Ethics in Washington (CREW) is a non-profit legal watchdog group dedicated to holding public officials accountable for their actions. For more information, please visit www.citizensforethics.org or contact Naomi Seligman at 202.408.5565 // nseligman@citizensforethics.org

CREW
Naomi Seligman
202-408-5565
nseligman@citizensforethics.org


Copyright © 2008 Business Wire. All rights reserved.
Share/Save/Bookmark

Article : CREW Asks for Investigation into Why Wall Street Is Getting H1N1 Vaccine Ahead of Those Who Most Need It
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News

Enigma Diagnostics Expands Its US and European Executive Management Teams
OXFORD, England and SAN DIEGO, Nov. 24 /PRNewswire/ -- Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today four senior appointments for its US and European offices. Dr. Jorge Garces will lead the US team as Presiden...

Leahy Hits U.S. Refusal to Join Landmine Treaty
WASHINGTON, Nov. 24 /PRNewswire-USNewswire/ -- Sen. Patrick Leahy (D-Vt.) is sharply critical of the Obama Administration's decision, announced Tuesday by the State Department, to decline to join the international treaty to ban anti-personnel landmines, a weapon that kills or maims thou...

OKI Electric Cable Launches VEYOR-CABLE™ Smooth-Sliding Parallel Robot Cables
KANAGAWA, Japan - OKI Electric Cable (TOKYO:5815) today

Taipei Starts Countdown to 2010 Flora Expo
TAIPEI,Taiwan - Taipei Mayor Hau Lung-bin announced on Nov. 6 the countdown of exactly 365 days to the opening of the 2010 Taipei International Gardening and Horticulture Exposition and urged other cities and counties of Taiwan to join Taipei City in putting Taiwan in the spotlight on the wo

Overstock.com Chairman and CEO Corrects Misstatements in Grant Thornton Letter to SEC
SALT LAKE CITY, Nov. 24 -- Overstock.com, Inc. (Nasdaq: OSTK) yesterday filed a Form 8-K/A which included a letter from the company's former auditor to the SEC. Below is a letter from Patrick Byrne, the company's Chairman and CEO, commenting on Grant Thornton...

EACOM Timber Corporation: Warrant Holders Exercise $2.4 Million of Warrants Early
VANCOUVER, BRITISH COLUMBIA -- 11/24/09 -- EACOM Timber Corporation (NEX: ETR.H) today announced it has received proceeds of $2,406,250 related to the early exercise of 9,625,000 warrants. These proceeds plus the Company's estimated $2 million in w..

Research and Markets: Asia Pacific Markets for Dental Implants and Final Abutments - Valued at Just Over US$480 Million in 2008
DUBLIN - Research and Markets (

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.